Unidad de gestión de proyectos
/es/servicios/unidades-de-apoyo/gestion-de-investigacion-proyectos
01 | 02 | 03 | 04 | |||
05 | 06 | 07 | 08 | 09 | 10 | 11 |
12 | 13 | 14 | 15 | 16 | 17 | 18 |
19 | 20 | 21 | 22 | 23 | 24 | 25 |
26 | 27 | 28 | 29 | 30 |
Convocatorias
2 resultados
13/04/2021
Añadir al calendario
2021-04-13 02:00:00
2021-05-06 02:00:00
Horizon: New calls for urgent research into coronavirus variants
To address the growing threat of coronavirus variants, the European Commission has launched four calls for research to complement earlier actions in the fight against SARS-CoV-2/COVID-19.
The Commission is mobilising €123 million to fund urgent research into coronavirus variants. This first emergency funding under Horizon Europe (the new EU research and innovation programme) contributes to the Commission’s actions to fight the pandemic and address the impact of variants in line with HERA Incubator, the new European bio-defence preparedness plan.
Projects that receive funding are expected to:
establish multi-centre, regional or multinational cohorts, including beyond Europe's borders;
further develop promising therapeutic or vaccine candidates against SARS-CoV-2/COVID-19;
strengthen research infrastructures to accelerate data sharing and research support.
HORIZON-INFRA-2021-EMERGENCY-01
FAIR and open data sharing in support to European preparedness for COVID-19 and other infectious diseases
HORIZON-INFRA-2021-EMERGENCY-02
Research infrastructure services for rapid research responses to COVID-19 and other infectious disease epidemics
HORIZON-HLTH-2021-CORONA-01-01
Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment
HORIZON-HLTH-2021-CORONA-01-02
Cohorts united against COVID-19 variants of concern
Location
Navarrabiomed
info@navarrabiomed
Europe/Madrid
public
06/04/2021
Añadir al calendario
2021-04-06 02:00:00
2021-04-27 02:00:00
INCORPORACIÓN DE NUEVOS GRUPOS AL CONSORCIO CIBER 2021
Ayudas para potenciar y fortalecer el Consorcio CIBER con dos medidas: por un lado, ampliando su estructura de I+D+I a través de la creación de una nueva área temática (Enfermedades infecciosas), conformadas por grupos de investigación que se incorporan al Consorcio CIBER con el fin de establecer programas de investigación conjuntos y, por otro, mediante la incorporación de nuevos grupos a los programas científicos que desarrolla actualmente el CIBER.
Áreas temáticas:
• Enfermedades infecciosas (46 grupos)
• Bioingenería, Biomateriales y Nanomedicina (1 grupo).
• Enfermedades respiratorias (3 grupos).
• Cáncer (2 grupos).
Location
Navarrabiomed
info@navarrabiomed
Europe/Madrid
public